These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3732311)

  • 21. Improved post-transfusion quality of density separated AS-3 red cells after extended storage.
    Keegan TE; Heaton A; Holme S; Owens M; Nelson EJ
    Br J Haematol; 1992 Sep; 82(1):114-21. PubMed ID: 1419784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a transfusion preparation of newly formed red cells and standard washed red cell transfusions in patients with homozygous beta-thalassemia.
    Collins AF; Gonçalves-Dias C; Haddad S; Talbot R; Herst R; Tyler BJ; Zuber E; Blanchette VS; Olivieri NF
    Transfusion; 1994 Jun; 34(6):517-20. PubMed ID: 8023393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective isolation of young erythrocytes for transfusion support of thalassemia major patients.
    Corash L; Klein H; Deisseroth A; Shafer B; Rosen S; Beman J; Griffith P; Nienhuis A
    Blood; 1981 Mar; 57(3):599-606. PubMed ID: 7459436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to the transfusion management of thalassemia.
    Propper RD; Button LN; Nathan DG
    Blood; 1980 Jan; 55(1):55-60. PubMed ID: 7350942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neocytes and neocyte-gerocyte exchange.
    Propper RD
    Prog Clin Biol Res; 1982; 88():227-33. PubMed ID: 7100213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deferasirox for managing iron overload in people with thalassaemia.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Motschall E; Niemeyer CM; Bassler D
    Cochrane Database Syst Rev; 2012 Feb; (2):CD007476. PubMed ID: 22336831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of young red cells for transfusion using the Fenwal CS 3000 cell separator.
    Pisciotto P; Kiraly T; Rosen D; Paradis L; Kakaiya RM; Morse EE
    Am J Hematol; 1984 Aug; 17(2):185-91. PubMed ID: 6465135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the supertransfusion regimen in homozygous beta-thalassaemia children.
    Masera G; Terzoli S; Avanzini A; Fontanelli G; Mauri RA; Piacentini G; Ferrari M
    Br J Haematol; 1982 Sep; 52(1):111-3. PubMed ID: 7115620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the diagnosis of erythrocyte enzyme defects in the presence of high reticulocyte counts.
    Lakomek M; Schröter W; De Maeyer G; Winkler H
    Br J Haematol; 1989 Jul; 72(3):445-51. PubMed ID: 2527553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo persistence of reticulocytes from donor red cells.
    Perry ES; Moore RH; Berger TA; Billups LC; Maybee DA; Salata KF; Lippert LE
    Transfusion; 1996 Apr; 36(4):318-21. PubMed ID: 8623131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reticulocytes in donor red cells.
    Branch DR
    Transfusion; 1997 Feb; 37(2):246. PubMed ID: 9051108
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 33. [Analysis of the shelf life and transfusion life of whole blood and erythrocyte concentrates].
    Strauss D; Richter H; Fünfhausen G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):550-9. PubMed ID: 2431978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Roberts DJ; Rees D; Howard J; Hyde C; Alderson P; Brunskill S
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004450. PubMed ID: 16235363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrokinetic studies in thalassaemia.
    Shahid MJ; Sahli IT
    Br J Haematol; 1971 Jan; 20(1):75-82. PubMed ID: 5540042
    [No Abstract]   [Full Text] [Related]  

  • 36. [Transfusion requirements and mean annual hemoglobin level in thalassemia major].
    Brunengo MA; Girot R
    Nouv Rev Fr Hematol (1978); 1986; 28(5):309-13. PubMed ID: 3808940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective trial of young red cells in 48 patients with transfusion-dependent thalassaemia.
    Marcus RE; Wonke B; Bantock HM; Thomas MJ; Parry ES; Taite H; Huehns ER
    Br J Haematol; 1985 May; 60(1):153-9. PubMed ID: 4005175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reticulocyte parameters of delta beta thalassaemia trait, beta thalassaemia trait and iron deficiency anaemia.
    Velasco-Rodríguez D; Alonso-Domínguez JM; González-Fernández FA; Villarrubia J; Sopeña M; Abalo L; Ropero P; Martínez-Nieto J; de la Fuente Gonzalo F; Cava F
    J Clin Pathol; 2016 Feb; 69(2):149-54. PubMed ID: 26265587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of blood transfusion on erythropoiesis of homozygotic beta-thalassemia patients].
    Deschamps A; Girot R; Maier-Redelsperger M; Cornu P
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):283-91. PubMed ID: 4081506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Separation of younger red cells with improved survival in vivo: an approach to chronic transfusion therapy.
    Piomelli S; Seaman C; Reibman J; Tytun A; Graziano J; Tabachnik N; Corash L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3474-8. PubMed ID: 277949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.